JUAN
SANCHIS FORES

2024

1. A rare case of inferior sinus venosus atrial septal defect and concomitant hypoplasia of the posterior mitral valve leaflet

   Echocardiography, Vol. 41, Núm. 9

2. Analysis of myocardial infarction incidence and case-fatality in the last three decades in the province of Girona

   Revista Espanola de Cardiologia, Vol. 77, Núm. 6, pp. 450-458

3. Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity

   Obesity Research and Clinical Practice, Vol. 18, Núm. 3, pp. 226-231

4. CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction

   Clinical Kidney Journal, Vol. 17, Núm. 8

5. Carbohydrate antigen 125-guided pre-TAVI medical optimization: impact on quality of life and clinical outcomes

   Revista Espanola de Cardiologia, Vol. 77, Núm. 9, pp. 750-758

6. Catheter-directed therapy for acute pulmonary embolism: results of a multicenter national registry

   Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 138-147

7. ChatGPT-4 versus human assessment in cardiology peer review

   Revista Espanola de Cardiologia, Vol. 77, Núm. 7, pp. 591-594

8. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes

   European Journal of Internal Medicine, Vol. 127, pp. 126-133

9. Differential sex-related effect of left ventricular ejection fraction trajectory on the risk of mortality and heart failure readmission following hospitalization for acute heart failure: A longitudinal study

   European Journal of Heart Failure, Vol. 26, Núm. 8, pp. 1687-1698

10. Effect of exercise training in patients with chronotropic incompetence and heart failure with preserved ejection fraction: Training-HR study protocol

    Current Problems in Cardiology, Vol. 49, Núm. 12

11. Effect of paced heart rate on quality of life and natriuretic peptides for stage B or C heart failure with preserved ejection fraction: A secondary analysis of the myPACE trial

    European Journal of Heart Failure, Vol. 26, Núm. 1, pp. 167-176

12. Exercise training response according to baseline ferrokinetics in heart failure with preserved ejection fraction: A substudy of the TRAINING-HF trial

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 15, Núm. 2, pp. 681-689

13. High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure

    Scientific Reports, Vol. 14, Núm. 1

14. Impact of Epicardial Adipose Tissue on Infarct Size and Left Ventricular Systolic Function in Patients with Anterior ST-Segment Elevation Myocardial Infarction

    Diagnostics, Vol. 14, Núm. 4

15. Improvement in left atrial strain following ferric carboxymaltose in heart failure: an analysis of the Myocardial-IRON trial

    ESC Heart Failure, Vol. 11, Núm. 2, pp. 1258-1262

16. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809

17. Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis

    European Heart Journal, Vol. 45, Núm. 23, pp. 2052-2062

18. Left ventricular volume and maximal functional capacity in heart failure with preserved ejection fraction: Size matters

    European Journal of Heart Failure

19. Lower heart rate in patients with acute heart failure: the role of left ventricular ejection fraction

    Scandinavian Cardiovascular Journal, Vol. 58, Núm. 1

20. Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management

    European Heart Journal, Vol. 45, Núm. 27, pp. 2380-2391